Korsana Biosciences

Korsana Biosciences

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://korsana.com/

Last Round

Seed

Feb 18, 2026

Total Funding Raised

$350M

Company Overview

Korsana Biosciences is a biotechnology company developing therapeutics for neurodegenerative diseases, with a lead program focused on a next-generation antibody for Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

neurodegenerative disease therapyblood-brain barrier shuttleAlzheimer's disease treatmentBBB shuttleantibody therapyamyloid beta targetingdrug delivery platformbiotechnologylarge molecule deliverydrug discoveryCNS disorderspreclinical biotechsubcutaneous administrationamyloid-related imaging abnormalitiesARIA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Korsana Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Korsana Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 18, 2026
Series ASep 1, 2025

Korsana Biosciences Investors

Notable investors and investment history

Korsana Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Korsana Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Korsana Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts
Year Founded2024
Last FundingFeb 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.